NO20050980L - Mikrobiologisk fremgangsmate for fremstilling av 7a-substituerte 11a-hydroksysteroider - Google Patents

Mikrobiologisk fremgangsmate for fremstilling av 7a-substituerte 11a-hydroksysteroider

Info

Publication number
NO20050980L
NO20050980L NO20050980A NO20050980A NO20050980L NO 20050980 L NO20050980 L NO 20050980L NO 20050980 A NO20050980 A NO 20050980A NO 20050980 A NO20050980 A NO 20050980A NO 20050980 L NO20050980 L NO 20050980L
Authority
NO
Norway
Prior art keywords
preparation
hydroxysteroids
substituted
microbiological process
compounds
Prior art date
Application number
NO20050980A
Other languages
English (en)
Inventor
Ludwig Zorn
Hans-Peter Muhn
Rolf Bohlmann
Norbert Gallus
Hermann Kuenzer
Reinhard Nubbermeyer
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10233723A external-priority patent/DE10233723A1/de
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO20050980L publication Critical patent/NO20050980L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J11/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P33/00—Preparation of steroids
    • C12P33/06—Hydroxylating
    • C12P33/08—Hydroxylating at 11 position
    • C12P33/10—Hydroxylating at 11 position at 11 alpha-position
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P33/00—Preparation of steroids
    • C12P33/12—Acting on D ring
    • C12P33/16—Acting at 17 position

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Reproductive Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

2005 -02- 2 3 En ny syntesefremgangsmåte for fremstillingen av utgangsprodukter for fremstillingen av forbindelser med generell formel (8, 10, 12) er beskrevet. I denne syntesen blir forbindelser med generell formel (4,B) fremstilt i en mikrobiologisk reaksjon. Betydningen av radikalene R7, R10, R11, R13, R17 og tillegg til for grupperingen U-V-W-X-Y-Z er indikert i kravene.
NO20050980A 2002-07-24 2005-02-23 Mikrobiologisk fremgangsmate for fremstilling av 7a-substituerte 11a-hydroksysteroider NO20050980L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10233723A DE10233723A1 (de) 2002-07-24 2002-07-24 Mikrobiologische Verfahren zur Herstellung von 7α-substituierten 11α-Hydroxysteroiden, daraus herstellbare 7α,17α-substituierte 11β-Halogensteroide, deren Herstellungsverfahren und Verwendung sowie pharmazeutische Präparate, die diese Verbindungen enthalten, sowie daraus herstellbare 7α-substituierte Estra-1,3,5(10)-triene
US40295302P 2002-08-14 2002-08-14
PCT/EP2003/008111 WO2004011663A2 (de) 2002-07-24 2003-07-24 Mikrobiologische verfahren zur herstellung von 7alpha-substituierten 11alpha-hydroxysteroiden

Publications (1)

Publication Number Publication Date
NO20050980L true NO20050980L (no) 2005-02-23

Family

ID=31189296

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20050980A NO20050980L (no) 2002-07-24 2005-02-23 Mikrobiologisk fremgangsmate for fremstilling av 7a-substituerte 11a-hydroksysteroider

Country Status (19)

Country Link
EP (1) EP1523568A2 (no)
JP (1) JP4417838B2 (no)
KR (1) KR101041328B1 (no)
CN (1) CN100339486C (no)
BR (1) BR0313210A (no)
CA (1) CA2492079C (no)
CO (1) CO5690563A2 (no)
CR (1) CR7672A (no)
EA (2) EA010572B1 (no)
EC (1) ECSP055630A (no)
HR (1) HRP20050172A2 (no)
IL (1) IL166358A0 (no)
MX (1) MXPA05001024A (no)
NO (1) NO20050980L (no)
NZ (2) NZ549529A (no)
PH (1) PH12005500143B1 (no)
PL (1) PL373808A1 (no)
RS (1) RS51855B (no)
WO (1) WO2004011663A2 (no)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103834712A (zh) * 2012-11-26 2014-06-04 复旦大学 去氧孕烯中间体纳米脂质体生物转化的优化方法

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1947107B1 (en) * 2005-10-27 2012-10-17 SRI International Process for production of steroid compound
RU2377309C1 (ru) * 2008-04-22 2009-12-27 Валентина Александровна Андрюшина МИКРОБИОЛОГИЧЕСКИЙ СПОСОБ ПОЛУЧЕНИЯ 7α-ГИДРОКСИАНДРОСТЕНОВ
CN103214543B (zh) * 2012-12-25 2015-09-02 中国人民解放军海军医学研究所 新山楂酸衍生物、其制备方法及其在抗肿瘤药物中的应用
CN104862323B (zh) * 2015-06-02 2018-01-16 中国农业科学院生物技术研究所 修饰苯二酚类化合物的羟化酶基因
PL246071B1 (pl) * 2022-08-26 2024-11-25 Wrocław University Of Environmental And Life Sciences Sposób wytwarzania 11α-hydroksy-19-nortestosteronu

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL75841C (no) 1949-06-11
US2658023A (en) * 1953-04-21 1953-11-03 Pfizer & Co C Oxygenation of steroids
US2985563A (en) 1958-11-13 1961-05-23 Schering Corp 11alpha-hydroxylation of steroids by glomerella
US3004047A (en) 1959-03-13 1961-10-10 Olin Mathieson 6alpha-halo-11alpha-hydroxy steroids of the pregnane series and esters thereof
US3341557A (en) 1961-06-05 1967-09-12 Upjohn Co 7-methyltestosterones
US3203869A (en) 1962-10-11 1965-08-31 Syntex Corp 11alpha-hydroxylation of 6-substituted-11-desoxy steroids with microorganisms of thegenus fusarium, liseola section
US5342834A (en) 1989-04-07 1994-08-30 The Population Council, Inc. Method for androgen supplementation
EP1167380A3 (en) 1995-12-11 2004-12-08 G.D. Searle & Co. 11.alpha.-hydroxy-steroid-4,6-dien-3-one compounds and a process for their preparation
GB9525194D0 (en) 1995-12-12 1996-02-07 Zeneca Ltd Pharmaceutical composition
CA2240315A1 (en) * 1995-12-12 1997-06-19 Akzo Nobel Nv Microbial 11.alpha.-hydroxylation of steroids
US20020012694A1 (en) 1997-09-17 2002-01-31 Alfred J. Moo-Young Transdermal administration of ment
US6767902B2 (en) 1997-09-17 2004-07-27 The Population Council, Inc. Androgen as a male contraceptive and non-contraceptive androgen replacement
US5952319A (en) 1997-11-26 1999-09-14 Research Triangle Institute Androgenic steroid compounds and a method of making and using the same
HUP0300128A3 (en) 2000-02-15 2004-03-29 Schering Ag Male contraceptive composition comprising norethisterone and its use
DE10104327A1 (de) * 2001-01-24 2002-07-25 Schering Ag 11beta-Halogensteroide, deren Herstellung und Verwendung zur Herstellung von Arzneimitteln sowie 11beta-Halogensteroide enthaltende pharmazeutische Präparate
AU2003251636B2 (en) * 2002-07-25 2009-10-22 Bayer Schering Pharma Aktiengesellschaft Composition containing an androgenous 11beta-halogen steroid and a progestational hormone, and male contraceptive based on said composition

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103834712A (zh) * 2012-11-26 2014-06-04 复旦大学 去氧孕烯中间体纳米脂质体生物转化的优化方法

Also Published As

Publication number Publication date
EP1523568A2 (de) 2005-04-20
KR101041328B1 (ko) 2011-06-14
WO2004011663A2 (de) 2004-02-05
JP4417838B2 (ja) 2010-02-17
CO5690563A2 (es) 2006-10-31
CA2492079A1 (en) 2004-02-05
EA200500224A1 (ru) 2005-08-25
HRP20050172A2 (en) 2005-04-30
MXPA05001024A (es) 2005-05-16
WO2004011663A9 (de) 2004-05-06
IL166358A0 (en) 2006-01-16
CA2492079C (en) 2012-01-10
EA010572B1 (ru) 2008-10-30
AU2003281677A1 (en) 2004-02-16
PH12005500143B1 (en) 2011-03-25
RS51855B (sr) 2012-02-29
JP2006503813A (ja) 2006-02-02
HK1081999A1 (zh) 2006-05-26
WO2004011663A3 (de) 2004-07-15
RS20050045A (sr) 2007-06-04
NZ549529A (en) 2008-04-30
CN1671858A (zh) 2005-09-21
BR0313210A (pt) 2005-06-28
EA008147B1 (ru) 2007-04-27
CR7672A (es) 2006-05-29
KR20050026507A (ko) 2005-03-15
MX260952B (no) 2008-10-01
EA200601030A1 (ru) 2006-10-27
ECSP055630A (es) 2005-04-18
CN100339486C (zh) 2007-09-26
PL373808A1 (en) 2005-09-19
NZ537871A (en) 2006-10-27

Similar Documents

Publication Publication Date Title
HUP0303283A2 (hu) Új piridinilcsoporttal szubsztituált pirazolopiridin-származékok, előállításuk és alkalmazásuk szív- és keringési betegségek kezelésére alkalmas gyógyszerkészítmény előállítására
HUP0302792A2 (hu) Dipeptidil peptidáz ciklopropil-kondenzált pirrolidin-bázisú inhibitorai és eljárás előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények
NZ526470A (en) Pyrazole compounds useful as protein kinase inhibitors
NZ528851A (en) N-aroyl cyclic amines
HUP9802859A2 (hu) Acil-amino-szalicilsav-amid-származékok és alkalmazásuk peszticidként
NZ536734A (en) Spiroindolinepiperidine derivatives
ID21547A (id) Kristal-kristal dari turunan benzimidazol dan produksinya
YU27304A (sh) Novi dihidropteridinoni, postupak za njihovo dobijanje i njihova primena kao lekova
NO20051225L (no) 1,2,4- oksadiazoler som modulatorer av metabotropisk glutamat-reseptor-5
NO20006645L (no) Ny form av irbesartan, fremgangsmåte for å oppnå den nevnte form og farmasöytiske preparater inneholdende den samme
NO20053890L (no) Syntese av 4-amino-2-butenolklorider og anvendelse derav for fremstilling av 3-cyanokinoliner
HRP20050359B1 (hr) Novi postupak za industrijsku sintezu stroncij renalata i njegovih hidrata
MX9800412A (es) Preparacion de 3-hidroxipirazoles n-substituidos.
NO20050980L (no) Mikrobiologisk fremgangsmate for fremstilling av 7a-substituerte 11a-hydroksysteroider
NO20010559L (no) Fremgangsmate for syntese av (1H)-benzo[c]kinolizin-3-ones derivater
NO20062599L (no) Fremgangsmate for syntese av perindopril og farmasoytisk akseptable salter derav
NO20055750L (no) Nye kjemiske forbindelser
MY139159A (en) Method for synthesis of perindopril and its pharmaceutically acceptable salts
HUP0302408A2 (hu) Új aminotriazolon-vegyületek, eljárás ezek előállítására és ezeket tartalmazó gyógyászati készítmények
NO20060733L (no) Pyrazoliner som PAR-1 antagonister for behandling av kardiovaskulaere sykdommer
MY135359A (en) New process for the synthesis of perindopril and pharmaceutically acceptable salts thereof
MXPA05013649A (es) Fluorbutenos nematicidas que contienen tiazolina.
NO20064352L (no) Fremgangsmate for fremstilling av pyrrolidinoksimer
MY139289A (en) Process for the synthesis of perindopril and pharmaceutically acceptable salts thereof
NO990285D0 (no) Tienylcykloheksan-derivater for tienylcykloheksyl-syntese

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application